The aim of this study was to investigate the frequency of anti-N-methyl-D-aspartate receptor (anti-NMDAR) antibody positivity in patients presenting with transverse myelitis (TM) and/or optic neuritis (ON), to describe their neurologic and radiological characteristics, and to compare these characteristics with those reported in previous studies.
Material and methods
This study included 179 patients (ON: 96, TM: 74, ON and TM: 9) who visited Isfahan Multiple Sclerosis Center from January 2017 to September 2019, for approximately 32 months. The respective neurological examinations were performed. Demographic data of the patients, as well as findings from radiological and serological investigations were obtained.
Frequencies of anti-NMDAR seropositivity in patients with TM, ON, and concurrent TM and ON were approximately 3.4%, 1.4%, and 11.1%, respectively. None exhibited any psychiatric symptoms.
Based on the frequency of seropositivity for anti-NMDAR antibody in our patients, positivity for this antibody appears to be more frequent than previously anticipated in patients presenting with these conditions. We recommend that the anti-NMDAR antibody presence in CSF/serum be checked and considered in addition to the routine examinations performed upon confronting demyelinating conditions such as TM and ON. We suggest considering the term “NMDAR spectrum disorder” to more clearly distinguish the potentially overlapping conditions with different etiologies in patients with CNS disorders.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, Vicari AM (1988) Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 318(16):1012–1020
Clapham DE (2007) Calcium signaling. Cell 131(6):1047–1058
Li F, Tsien JZ (2009) Memory and the NMDA receptors. N Engl J Med 361(3):302–303
Paoletti P, Bellone C, Zhou Q (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14(6):383–400
Rosenfeld MR, Dalmau J (2011) Anti–NMDA-receptor encephalitis and other synaptic autoimmune disorders. Curr Treat Options Neurol 13(3):324–332
Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A et al (2007) Paraneoplastic anti–N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61(1):25–36
Schermann H, Ponomareva IV, Maltsev VG, Yakushev KB, Sherman MA (2019) Clinical variants of limbic encephalitis. SAGE Open Med Case Rep 7:2050313X19846042
Graus F, Saiz A, Dalmau J (2010) Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257(4):509–517
Cobo-Calvo Á, Gracia CI, Quiñones SM, Torro CM, Saiz A, Dalmau J, Martínez-Yélamos S (2014) Optic neuritis in the setting of NMDA receptor encephalitis. J Neuroophthalmol 34(3):316–319
Takei K, Sato M, Nakamura M, Shimizu H (2015) Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up. Case Reports 2015:bcr2015212112
Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098
Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15(4):391–404
Liu CY, Zhu J, Zheng XY, Ma C, Wang X (2017) Anti-N-methyl-D-aspartate receptor encephalitis: a severe, potentially reversible autoimmune encephalitis. Mediat Inflamm 2017:1–14
Yoshimura B, Takaki M (2017) Anti-NMDA receptor antibody positivity and presentations without seizure, involuntary movement, hypoventilation, or tumor: a systematic review of the literature. J Neuropsychiatry Clin Neurosci 29(3):267–274
Beasley SJ, Greer JMJC, Neuroimmunology E (2015) Autoantibodies and their potential roles in diseases of the nervous system. 6(4):370–386
Káradóttir R, Cavelier P, Bergersen LH, Attwell D (2005) NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438(7071):1162–1166
Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T et al (2014) Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol 75(3):411–428
Ramberger M, Bsteh G, Schanda K, Höftberger R, Rostásy K, Baumann M, Aboulenein-Djamshidian F, Lutterotti A, Deisenhammer F, Berger T, Reindl M (2015) NMDA receptor antibodies: a rare association in inflammatory demyelinating diseases. Neurology-Neuroimmunol Neuroinflamm 2(5):e141
Salter MG, Fern R (2005) NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438(7071):1167–1171
Dambinova SA, Khounteev GA, Izykenova GA, Zavolokov IG, Ilyukhina AY, Skoromets AA (2003) Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem 49(10):1752–1762
Izykenova G, Granstrem O, Gappoeva M, Dambinova S (2001) Autoantibodies to NMDA receptor in chronic cerebral ischemia. J Stroke Cerebrovasc Dis 10:195
Bokesch PM, Izykenova GA, Justice JB, Easley KA, Dambinova SA (2006) NMDA receptor antibodies predict adverse neurological outcome after cardiac surgery in high-risk patients. Stroke 37(6):1432–1436
Kolls BJ, Meyer RL (2013) N-methyl-D-aspartate receptors strongly regulate postsynaptic activity levels during optic nerve regeneration. J Neurosci Res 91(10):1263–1279
Li C, Xiao L, Liu X, Yang W, Shen W, Hu C, Yang G, He C (2013) A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination. Glia 61(5):732–749
Hacohen Y, Absoud M, Hemingway C, Jacobson L, Lin JP, Pike M et al (2014) NMDA receptor antibodies associated with distinct white matter syndromes. Neurology-Neuroimmunol Neuroinflamm 1(1):e2
Yang HK, Kim JH, Park YH, Park KS, Kim JS, Hwang JM (2017) Anti-NMDA-receptor optic neuritis in a patient with a history of encephalitis. Can J Ophthalmol 52(6):e216–e218
Ishikawa N, Tajima G, Hyodo S, Takahashi Y, Kobayashi M (2007) Detection of autoantibodies against NMDA-type glutamate receptor in a patient with recurrent optic neuritis and transient cerebral lesions. Neuropediatrics 38(05):257–260
Johnston J, Ali K, Pearson OR, Rickards C, Vincent A (2010) POI14 multiple sclerosis: a potential association with anti-N-methyl-d-aspartate receptor encephalitis. J Neurol Neurosurg Psychiatry 81(11):e56–e56
Lekoubou A, Viaccoz A, Didelot A, Anastasi A, Marignier R, Ducray F, Rogemond V, Honnorat J (2012) Anti-N-methyl-D-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features. Eur J Neurol 19(2):e16–e17
Pennington C, Livingstone S, Santosh C, Razvi S (2012) N-methyl D-aspartate receptor antibody encephalitis associated with myelitis. J Neurol Sci 317(1–2):151–153
Takeda A, Shimada H, Tamura A, Yasui M, Yamamoto KI, Itoh K et al (2014) A case of anti-N-methyl-D-aspartate receptor encephalitis with multiple sclerosis-like demyelinated lesions. Multiple Scler Relat Disord 3(3):391–397
Kruer MC, Koch TK, Bourdette DN, Chabas D, Waubant E, Mueller S, Moscarello MA, Dalmau J, Woltjer RL, Adamus G (2010) NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology 74(18):1473–1475
Outteryck O, Baille G, Hodel J, Giroux M, Lacour A, Honnorat J, Zéphir H, Vermersch P (2013) Extensive myelitis associated with anti-NMDA receptor antibodies. BMC Neurol 13(1):211
Conflict of interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Etemadifar, M., Abhari, A.P., Sabeti, F. et al. “NMDA receptor spectrum disorder” in the differential diagnosis of demyelinating disorders of the CNS: optic neuritis and myelitis. Neurol Sci (2020). https://doi.org/10.1007/s10072-020-04518-y
- NMDA receptor
- Optic neuritis
- Transverse myelitis
- NMDAR spectrum disorder